On Feb 7, 2022 Endeavor BioMedicines closed a Series B round and raised $101,000,000 from Ally Bridge Group, Avidity Partners, Longitude Capital, Omega Funds, Perceptive Advisors, Piper Heartland Healthcare Capital, Revelation Partners, T. Rowe Price, Tekla Capital Management, featuring lead investors Ally Bridge Group, Avidity Partners.

About the company: Endeavor BioMedicines is located at United States, North America.
“At Endeavor BioMedicines, our team’s drive is to live up to our name and mission to help patients feel better and live longer.”

Company website: http://www.endeavorbiomedicines.com